Two complementary instrumental techniques were used, and the data generated was processed with advanced numerical tools to investigate the interactions between anti-human apoB-100 monoclonal antibody (anti-apoB-100 Mab) and apoB-100 containing lipoproteins. Partial Filling Affinity Capillary Electrophoresis (PF-ACE) combined with Adsorption Energy Distribution (AED) calculations provided information on the heterogeneity of the interactions without any a priori model assumptions. The AED calculations evidenced a homogenous binding site distribution for the interactions. Quartz Crystal Microbalance (QCM) studies were used to evaluate thermodynamics and kinetics of the Low-Density Lipoprotein (LDL) and anti-apoB-100 Mab interactions. High affinity and selectivity were observed, and the emerging data sets were analysed with so called Interaction Maps. In thermodynamic studies, the interaction between LDL and anti-apoB-100 Mab was found to be predominantly enthalpy driven. Both techniques were also used to study antibody interactions with Intermediate-Density (IDL) and Very Low-Density (VLDL) Lipoproteins. By screening affinity constants for IDL-VLDL sample in a single injection we were able to distinguish affinity constants for both subpopulations using the numerical Interaction Map tool.
Introduction
Variety of techniques are available for evaluation of affinity constant (KA), but they usually require either chemical modifications of the reactants, or indirect measurements. These techniques include affinity chromatography, radioimmunoassay, enzyme-linked immunosorbent assay, X-ray diffraction, nuclear magnetic resonance, mass spectroscopy, fluorescence-based methods, and isothermal titration calorimetry. Modern biosensor techniques like Quartz Crystal Microbalance (QCM) and surface plasmon resonance, as well as Partial Filling Affinity Capillary Electrophoresis (PF-ACE), allow the determination of affinity constants without any reactant modifications. QCM can measure association and dissociation rate of the molecules, and can be thus utilized to study kinetics and thermodynamics at different temperatures. PF-ACE on the other hand, with the combination of Adsorption Energy Distribution (AED) calculations, has proven to work as a sole method for the investigation of demanding biomolecular interactions [1] . In PF-ACE the reagents are flowing freely in a solution, as compared to QCM, where immobilization of one of the reagents is needed. PF-ACE/AED can be successfully used for elucidation of the heterogeneity of interactions, and determination of affinity constant [1] [2] [3] [4] .
When biosensors are used for affinity studies, it is relatively easy to generate data, while correct data interpretation may be problematic [5] . With poor experimental design and data interpretation, it is not unusual that biosensor data does not agree with the results achieved with other techniques [5] . To be able to use a simple binding isotherm with 1:1 interaction model, the response of the QCM should reach the plateau, in other words reach equilibrium, before the end of the analyte injection, which is called equilibrium analysis. In that case, affinity constants obtained with simple 1:1 kinetic model agree with equilibrium analysis, although in case of IgG molecule the 1:2 equilibrium is more typical. When all responses of the analyte injection reach the equilibrium, the equilibrium analysis can be used, in other cases it is not applicable [5] .
However, for some biological systems more complex fitting models are required, combined with better ways to present the data.
Low Density Lipoproteins (LDL), Intermediate Density Lipoproteins (IDL) and Very Low-Density Lipoproteins (VLDL) are the major carriers of triglycerides and cholesterol in human circulation [6] . They consist mainly of hydrophobic core containing cholesteryl esters, triglycerides, fatty acids and fat-soluble vitamins, and the hydrophilic surface of apolipoproteins, phospholipids and un-esterified cholesterol [7] . ApoB-100 is the major apolipoprotein in LDL, IDL and VLDL, as well as in Lp(a), a specific LDL-and apo(a)containing complex. Main function of apoB-100 is to control the structural integrity of these lipoproteins, as well as to control their receptor-mediated removal from the circulation and other cellular interactions. The size of LDL particle is approximately 22 nm and can vary between 80-200 nm for VLDL particles [7] . Due to their complex nature, the lipoproteins have different sizes, masses and compositions and these metrics vary from one individual to other.
Ultracentrifugation separates the lipoprotein species based on their hydrated density differences in a heterogeneous mass and size mixture. This affects especially the QCM experiments, since kinetics of association and dissociation for LDL particles with smaller particle diameter is different compared to that at the larger end of the size distribution. Complex fitting models are thus required, and the interactions can be presented as sensograms with model fits or even as an Interaction Map, which shows the distribution of association and dissociation constants.
In this study, mouse anti-human apoB-100 monoclonal antibody (anti-apoB-100 Mab) was used to study the interactions between lipoproteins containing apoB-100. PF-ACE/AED was exploited as a reference technique to QCM with Interaction Maps. PF-ACE/AED provided the information on the heterogeneity of the interaction, and QCM was used to investigate the kinetics and thermodynamics at different temperatures. Both techniques were employed to determine the affinity constants and they were evaluated in term of applicability for kinetic and thermodynamic information. The specificity of anti-human apoB-100 monoclonal antibody towards apoB-100 was evaluated by PF-ACE and its interaction with HDL2 including no apoB-100. 
Material and methods

Chemicals and materials
Instrumentation
The Attana A100 Quartz Crystal Microbalance (QCM) instrument (Attana AB, Stockholm, Sweden) was used for label-free analyses of molecular interactions. LNB-Carboxyl sensor chips (Attana AB) providing low non-specific binding were used as the assay surface [2, 3, 8, 9] . Chamber and sample volumes were 1. Ultracentrifugation was made using Beckman Optima TL Table-Top 
Preparation of buffers and solutions
Phosphate buffer (I = 20 mM) used in CE and QCM experiments was prepared by adding 485 μl of phosphoric acid (85%) and dissolving it with 14.16 ml of 1.0 M NaOH to 900 ml of Milli-Q water. The pH of the solution was first adjusted to 7.4 with 1.0 M HCl and then filled to the final volume of 1000 ml with Milli-Q water. To calculate the ionic strength of the buffer, pKa,2 of 7.2 [10] was used for phosphoric acid.
In isolation of the biological compounds with dialysis studies the solution was phosphatebuffered saline (PBS, pH 7.4). It was prepared following the standard procedure. 1M ethanolamine solution (pH 9.0) was prepared by adjusting the pH with hydrochloric acid (fuming 37%). Preparation of 0.28 M ammonium hydroxide (pH 11.5) was done by dissolving 1.13 ml of 25% ammonia into the 50 ml of Milli-Q water.
Phosphate buffer (I = 20 mM) was used to dilute anti-apoB-100 Mab (100 µg/ml) for using the antibody in amine coupling on the LNB-Carboxyl layer on the biosensor chips. The buffer (10 mM HEPES, 150 mM NaCl, 0.005% Tween 20, pH 7.4) for the immobilization was prepared 
Production of monoclonal antibody
Monoclonal antibody was produced in vitro using mouse hybridoma production technology.
Splenocytes were collected from the immunized mouse and the highest antisera titer were fused with myeloma cells [11] . Mice were immunized with highly purified human LDL. In vitro cultured hybridoma cells secreted specific anti-human apoB-100 monoclonal antibody (IgG1 class) in culture medium. The antibody was purified by protein affinity chromatography. Clear solution of purified IgG1 subclass was made in 50 mM Na-citrate, pH 6.0, 0.9% NaCl containing 0.095 % NaN3 as anti-bacterial agent and stored at +4 o C. Before use the solution was dialyzed against phosphate-buffered saline (PBS, pH 7.4). Epitope in apoB-100 polypeptide chain recognized by this established anti-apoB-100 Mab is not known.
Isolation and characterization of Low Density Lipoprotein (LDL)
Human LDL (d = 1.019-1.050 g/ml) was isolated by sequential ultracentrifugation in the presence of 3 mmol/l Na2EDTA [12, 13] . First, EDTA and 100 µg/ml gentamycin sulfate were added to the plasma sample and the density was adjusted to 1.019 with KBr. Then, the plasma sample was centrifuged at 40 000 rpm (rotor 50.2 Ti, gmax 302 000) at +4°C for 24 h. The IDL-VLDL fraction was collected from the top and the density of the remaining plasma was set to 1.050 g/ml with KBr. The density-adjusted plasma was centrifuged at 40 000 rpm for 72 h and the plasma for further steps was collected on the top of the solution. The collected solution was re-centrifuged at a density of 1.063 g/ml for 24 h, collected and dialyzed extensively against 150 mM NaCl -1 mM EDTA (pH 7.4) followed by dialysis against phosphate-buffered saline (PBS, pH 7.4) which was used for CE analyses. The amounts of LDL and VLDL-IDL are expressed in terms of the protein concentration. The concentrations including that of anti-apoB-100 Mab were determined by the method of Lowry et al. [14] or by BCA protein assay kit (Pierce, Rockford, IL) using bovine serum albumin as the standard. Molar concentrations of LDL, IDL-VLDL were calculated using molecular weight of apoB-100 (512 kDa). For anti-apoB-100 Mab, molecular weight of 155 kDa was used.
Isolation of high-density lipoprotein (HDL2)
HDL2 was isolated from serum and plasma samples by sequential ultracentrifugation and KBr was used for density adjustment. After the first isolation of apoB-containing lipoproteins at d = 1.063 g/mL (5°C, 3h, 500,000 x g), the infranatant fraction was adjusted to density 1.125 g/mL with solid KBr and then centrifuged (5°C, 18h, 500,000 x g). The HDL2 was obtained in top fraction. The purity of the isolated HDL2 was checked with FPLC size-exclusion chromatography. The isolated HDL2 was dialyzed against phosphate-buffered saline (PBS, pH 7.4) and stored at -80°C before analysis.
Sample preparation
The solutions of anti-apoB-100 Mab (0.0002 -0.1 mg/ml) used as binding ligand in PF-ACE experiments were diluted in phosphate buffer (I = 20 mM). In addition, LDL (0.075 mg/ml), IDL-VLDL (0.036 mg/ml), and HDL2 (0.2 mg/ml) used as the antigens in PF-ACE were diluted in phosphate buffer (I = 20 mM). DMSO (1% v/v) was dissolved in Milli-Q water.
Immobilization solution was prepared in the same manner as mentioned above from phosphate, but pH was adjusted to 6.4 with 1.0 M HCl.
Immobilization of anti-apoB-100 Mab on LNB-Carboxyl sensor chip
Immobilization of anti-apoB-100 Mab was done with amine coupling procedure according to interactions were studied at 37.0 o C. LDL and IDL-VLDL concentrations ranged from 3 to 110 µg/ml. Three repetitions were made to verify the precision of the data. In this study, we assume that the Sauerbrey relation is valid and that the QCM frequency shifts are proportional to the adsorbed amount of solute [15] .
QCM analysis of anti-apoB-100 Mab -lipoprotein interactions
The measurements started after the waiting period of 20 minutes to stabilize the resonant frequency. LDL and IDL-VLDL samples were injected to the surface of chips, monitoring first the association for 50 seconds and then the dissociation for 500 seconds. After each association and dissociation cycle, the biosensor chip was regenerated with injection of 0.28 M ammonium hydroxide (pH 11.5) and re-equilibrated with the analysis buffer.
Estimation of kinetic rate constants
Estimation of kinetic rate constants is an inverse problem, i.e., a problem where given the response of the system we want to estimate system parameters. Here we are going to estimate system parameter distributions rather than a finite set of system parameters values.
In general, assuming that the total measured response, Rtot, of a system can be written as a linear combination of some individual responses r (e.g. Rtot is the sum of the responses for all one-toone interactions for biosensors) we have that,
where x is the independent variable(s) for the system, e.g. the analysis time, p is the system parameter(s), e.g. rate constants, and a is a constant. If we let n in Eq. (1) → ∞ we get that,
where Ω m is the considered system parameter space. Eq. (2) 
where M is a matrix and a, Rtot are discrete sample vectors of a(p) and Rtot(x), respectively. Eq.
(3) is usually an ill-conditioned over-or underdetermined linear system and often the condition a ≥ 0 is imposed. In order to get reasonable solutions to Eq. (3) 
where Γ is a regularization matrix (usually an identity or Laplacian matrix) and λ is a regularization parameter.
For biosensors the kernel R in Eq.
(2) can be written,
where t (analysis time) and C (analyte concentration) are the independent variables and ka, (association rate constant) and kd (disassociation rate constant) are non-negative system parameters. Above t0 is the time when the injection of the analyte begins and tinj is the injection time. The solution a(ka, kd) to Eq. (2) with the kernel in Eq. (5) is known as an Interaction Map [16, 17] , see Figs. 3 and 5. The Interaction Maps in this study were calculated using the TraceDrawer software from Ridgeview Instruments AB, Sweden.
Capillary electrophoresis coating procedure
Unfavorable adsorption of lipoproteins on the negatively charged fused-silica capillary was diminished by coating the capillary inner wall with quaternized double-hydrophilic poly(Nmethyl-2-vinyl pyridinium iodide-block-ethylene oxide) (P2QVP-b-PEO) diblock copolymer [18] . P2QVP-b-PEO (0.1 mg/ml) was dissolved in Milli-Q water. Coating procedure was slightly modified from previous studies [1, 18] . First an uncoated fused-silica capillary was pretreated by flushing for 15 min, 10 min, and 10 min with 0.1 M NaOH, Milli-Q water, and phosphate buffer (pH 7.4, I = 20 mM) at the pressure of 940 mbar. Then the capillary was flushed for 20 min, 10 min, 25 min, and 5 min with 1 M HCl, 0.1 M HCl, Milli-Q water, and the pH 7.4 phosphate buffer, respectively, at the pressure of 940 mbar. After pretreatment, the voltage of +15 kV was applied for 5 min. The P2QVP-b-PEO coating solution was then applied for 40 min and left for 30 min to react with the silanol groups on the capillary surface. Excess copolymer solution in phosphate buffer was then rinsed by flushing through the capillary for 60 min at the pressure of 940 mbar. The coating procedure with the polymer solution was repeated twice to ensure the best possible stability of the wall coating. The whole procedure was conducted at 37.0 o C. To ensure the success of the coating, electro-osmotic flow (EOF) mobility was measured using DMSO with the Williams and Vigh method [19] . The stability of the mobility value was controlled also during the kinetic studies. It was to be at the level of 10 -9 -10 -10 m 2 V -1 s -1 .
Partial filling procedure
Partial filling (PF) procedure in CE was slightly modified from our previous studies [1] [2] [3] [4] 20] .
Briefly, negatively charged analytes were hydrodynamically introduced to the coated capillary.
First, slightly negative anti-apoB-100 Mab was introduced in the concentration range of 0.0002 to 0.1 mg/ml for 3 s, followed by injection of the more negative lipoproteins at 50 mbar pressure [18] . The lipoprotein concentrations were different in the antibody-antigen reactions. LDL (0.075 mg/ml) was introduced for 2s, IDL-VLDL (0.0036 mg/ml) for 8s, and HDL2 (0.20 mg/ml) for 2s at 50 mbar. When the voltage of -25 kV was applied and detector was in the cathode end, more anionic lipoproteins reached anti-apoB-100 Mab and formed the LDL -anti-apoB-100 Mab complex and the IDL-anti-apoB-100 Mab and the VLDL -anti-apoB-100 Mab complexes. HDL2 lacking apoB-100 was used as a control to test the specificity of the anti-apoB-100 Mab. The detection was performed at the wavelength 200 nm. Before each run, the capillary was rinsed for 2 min with the phosphate buffer (pH 7.4). All the experiments were conducted at 37.0 o C. After every second run, the EOF mobility was measured to control the stability of the coating.
Determination of affinity constants with PF-ACE
To determine the affinity constants for complexes between LDL, ILD-VLDL and anti-apoB-100 Mab, the AED calculations were used. First, the LDL or IDL-VLDL fractions, bound to anti-apoB-100 Mab, were established as a function of anti-apoB-100 Mab concentrations. The interactions were studied by injecting anti-apoB-100 Mab with increasing concentrations, followed by a constant LDL or IDL-VLDL concentration and volume. Then the voltage was applied and LDL or IDL-VLDL having more charges than anti-apoB-100 Mab reached the anti-apoB-100 Mab and interacted with it. The average mobility of the antibody-antigen complex can be described with following equation [21] :
where Θf and Θb are the free and bound fractions of LDL or IDL-VLDL, respectively, and μf and μb are the mobilities of free and bound LDL or IDL-VLDL to anti-apoB-100 Mab, and μ A is the average mobility of the complex. Since Θf + Θb = 1, equation of adsorbed fraction can be presented as:
The mobilities of the adsorbed and free fractions were investigated with exponential and linear fitting, respectively. At the lower end of the concentration range, electrophoretic mobility decreased linearly towards the minimum value, where LDL or IDL-VLDL was in free form. At the high concentration end, where LDL or IDL-VLDL was completely bound to anti-apoB-100
Mab, electrophoretic mobility reached the maximum value.
Adsorption isotherms and adsorption energy distribution
Adsorption isotherms describe the fraction of analyte adsorbed or in free solution at equilibrium to a constant and specific temperature [22, 23] . Langmuir model describes adsorption to a limited number of equal adsorption sites can be expressed as:
where C is the analyte concertation in the running buffer,  is fractional surface coverage and KA is the association equilibrium constant. As described above the Langmuir model can only describe one type of interaction. However, many adsorption processes are a result of several different type of interactions such as ion-ion, hydrophobic interactions etc. One simple way to model heterogeneous adsorption process is to use the bi-Langmuir adsorption isotherm. The Bi-Langmuir model is just the sum of two Langmuir models, and can be presented as:
Here, indices 1 and 2 denote the first and second adsorption sites, respectively.  S,i is the saturation fraction for the i:th site. Observe that  S,1 +  S,2 = 1. One other way to describe heterogeneous adsorption is to expanding the Langmuir adsorption isotherm model into a continuous distribution of independent homogeneous sites across a certain range of adsorption energies as done below [3, 24] :
Here, θ(C, KA) is the local adsorption model, and f(ln KA) is the adsorption energy distribution (AED). KA,min and KA,max are determined from the inverse maximum and minimum sample concentration used in the CE experiments. In this study, the AED is solved using the expectation maximization method, where the integral equation is iteratively solved [25] . Observe that both the AED in Eq. (10) and Interaction Maps are Inhomogeneous Fredholm Integral Equations of the first kind with kernel θ(C, KA), see Eq. (2) .
Results and discussion
Interactions between anti-apoB-100 Mab and lipoprotein were studied with PF-ACE/AED and QCM with Interaction Map. In PF-ACE studies, anti-apoB-100 Mab was freely floating in background electrolyte solution under physiological buffer conditions so in that sense the system resembles conditions in general blood circulation. However, in the QCM studies were carried out under the same conditions where anti-apoB-100 Mab was immobilized covalently onto the chip surface. Due to its high reliability, the QCM system allowed to study the kinetics and the thermodynamics of the antibody-antigen interactions.
Partial filling affinity capillary electrophoresis
Adsorption isotherms for the interactions between LDL, IDL-VLDL and anti-apoB-100 Mab were determined at 37 o C by PF-ACE. To avoid non-specific adsorption of lipoproteins onto the negatively charged fused silica capillary surface, the capillary inner wall was coated with P2QVP-b-PEO diblock copolymer [18] . The coating was freshly prepared for each interaction study. EOF mobilities of every second run were monitored using Williams and Vigh method [19] to correct the migration times of the analytes. Since lipoproteins have higher mobilities due to their negative charges than the anti-apoB-100 Mab that is almost immobile at pH 7.4 (pI 7.0), they were hydrodynamically introduced into the capillary after anti-apoB-100 Mab, and they reached anti-apoB-100 Mab in the capillary resulting in quick antibody-antigen immunocomplex formation. As expected no complex was formed between anti-apoB-100 Mab and HDL2 lacking apoB-100. This confirmed the specific nature of anti-apoB-100 Mab towards apoB-100 containing lipoproteins, leading to migration time changes of apoB-100 Mab complexes with LDL and IDL-VLDL ( Fig.1) . We also observed that system peaks in the beginning of the electropherograms were caused by anionic ions caused by bromide ion of KBr that was used to adjust density of the lipoproteins in the ultracentrifugation. This was eliminated by replacing the ultracentrifugation medium with PBS solution resulting in bromide free broad IDL-VLDL peak (Fig. 1 B) . Electropherograms of Fig. 1 provided the raw adsorption isotherm data for LDL and IDL-VLDL, see Eq. (7) . The affinity constants were calculated from Scatchard plot analysis and heterogeneity of the adsorption isotherm models were analyzed with AED calculations using the median values of the adsorption data for LDL, IDL-VLDL and anti-apoB-100 Mab systems at 37 o C. Fig. 2 demonstrates a single site model adsorption. Table   1 shows the affinity constant for LDL and anti-apoB-100 Mab interaction obtained by PF-ACE/AED, while Table 3 lists the affinity constants for IDL-VLDL and anti-apoB-100 Mab interaction. A slightly higher affinity constant (KA = (4.94 ± 1.33)•10 7 M -1 , log KA = 7.69) was measured for interaction between IDL-VLDL and anti-apoB-100 Mab compared to that between LDL and anti-apoB-100 Mab (KA = (2.54 ± 0.88)•10 7 M -1 , log KA = 7.41).
Effect of temperature on affinity and kinetics studied by QCM
To study the effect of temperature on the affinity and kinetics of the interactions between LDL and anti-apoB-100 Mab by QCM, the following temperatures were used 25.0, 34.0, 35.0, 36.0, 37.0, 38.0, 39.0, and 40.0 o C. The data points were determined three times at specified temperature. Fig. 3 shows selected sensorgrams, along with model fits for association and dissociation, as well as Interaction Maps at 37 o C. The response and representative QCM sensograms at all the concentrations employed for LDL can be found in Figs. S1 and S2. The kinetics and affinity parameters at 37 o C were estimated from the Interaction Map peak using Ridgeview software and thereby kinetic parameters, such as association rate constant (8.61·10 5 M −1 s −1 ) and dissociation rate constant (9.55·10 -3 s −1 ) were obtained. Affinity constant (KA = 9.02•10 7 M -1 , log KA = 7.96) for LDL and anti-apoB-100 Mab was calculated from the ratio of binding rate constants KA = 1/(kd/ka). The kinetics and affinity parameters for LDL and anti-apoB-100 Mab interactions at other temperatures were evaluated following the same procedure. Table 1 measured from the QCM experiments it can be seen that while the association rate constant stayed relatively unchanged when going from 25 to 40 o C, the dissociation rate constant increased 10-fold, resulting also in 10-fold loss in affinity from 4.68·10 8 to 4.57·10 7 M -1 (log KA = 8.67 to log KA = 7.66).
From the data in
Thermodynamic studies carried out by quartz crystalline microbalance
In this study, the QCM sensor was used to provide thermodynamic parameters, which can be used to elucidate if LDL and anti-apoB-100 Mab interaction is enthalpy or entropy driven. Data received from Interaction Maps ( Table 1) were used. When enthalpy change is not temperature dependent van't Hoff plot (lnK vs 1/T) results in a linear slope -∆H/R [26] , and thermodynamic parameters can be obtained from the following equation:
where K is association constant, ∆ is change in entropy, ∆H is enthalpy change, T is temperature, and R being the gas constant 8.314 JK -1 mol -1 . Fig. 4 shows van't Hoff plot of lnK as a function of 1/T, which appears to be nearly linear, indicating that enthalpy change (∆H) was temperature independent. The results ( Table 2) calculated from the van't Hoff plot indicate that interaction between LDL and anti-apoB-100
Mab is predominantly enthalpy driven, resulting in the following thermodynamic parameters: ∆H = -116.7 kJ mol −1 , and ∆S = -225.0 J K −1 mol −1 .
Study of IDL-VLDL and anti-apoB-100 Mab interactions
QCM was also used to elucidate the interactions at physiological temperature 37 o C between anti-apoB-100 Mab and IDL-VLDL that were co-isolated without separation by ultracentrifugation. Similarly to LDL studies, each of the data point was determined three times. From the Interaction Map (Fig. 5 ) it is evident that the interactions between anti-apoB-100 Mab and IDL-VLDL produced two peaks that represented binding-like processes with distinct kinetic parameters. Association rate constant for site 1, which represents the highest peak with a weight of 64% was 5. Table 3 .
QCM study of LDL, IDL-VLDL and anti-apoB-100 Mab interactions at 37 o C gave slightly higher affinity for IDL-VLDL (log KA = 8.00, site 1) than for LDL (log KA = 7.96), supported by PF-ACE/AED studies (Fig. 2 , Tables 1 and 3 This was also noticed by Guha et al., who concluded that structural stability of LDL and VLDL is determined by kinetic barriers, resulting in decelerated interconversion among lipoprotein subclasses and classes [27] . IDL also forms a minor component in the isolated IDL-VLDL fraction, and due to the different masses and overall compositions, the IDL and VLDL interacted with anti-apoB-100 Mab with different kinetics resulting in two peaks in the Interaction Map (Fig. 5 ). Isolated LDL sample resulted on the other hand demonstrated only one peak in the Interaction Map (cf. Fig. 3 ). 
Conclusions
TABLES
